The cryo-EM structure of the human rhinovirus B14 determined in this study reveals 13-bp RNA duplexes symmetrically bound to regions around each of the 30 two-fold axes in the icosahedral viral capsid. The RNA duplexes (~12% of the ssRNA genome) define a quasi-dodecahedral cage that line a substantial part of the capsid interior surface. The RNA duplexes establish a complex network of non-covalent interactions with pockets in the capsid inner wall, including coulombic interactions with a cluster of basic amino acid residues that surround each RNA duplex. A direct comparison was made between the cryo-EM structure of RNA-filled virions and that of RNA-free (empty) capsids that resulted from genome release from a small fraction of viruses. The comparison reveals that some specific residues involved in capsid-duplex RNA interactions in the virion undergo remarkable conformational rearrangements upon RNA release from the capsid. RNA release is also associated with the asynchronous opening of channels at the 30 two-fold axes. The results provide further insights into the molecular mechanisms leading to assembly of rhinovirus particles and their genome uncoating during infection. They may also contribute to development of novel antiviral strategies aimed at interfering with viral capsid-genome interactions during the infectious cycle.
The rabbit hemorrhagic disease virus (RHDV) vaccine platform is a nanoparticle composed of 180 copies of the viral capsid protein, VP60, self-assembled into virus-like particles (VLPs). RHDV VLPs are able to accept the simultaneous incorporation of target epitopes at different insertion sites. The resulting chimeric RHDV VLPs displaying immunogenic foreign antigens have been shown to induce specific protective immune responses against inserted heterologous T-cytotoxic and B-cell epitopes in the mouse and pig models. In this study, we explored whether RHDV-based engineered VLPs can be developed as efficient multivalent vaccines co-delivering different foreign B-cell antigens. We generated bivalent chimeric RHDV VLPs displaying two model B-cell epitopes at different surface-exposed insertion sites, as well as the corresponding monovalent chimeric VLPs. The immunogenic potential of the bivalent chimeric VLPs versus the monovalent constructs was assessed in the mouse model. We found that the bivalent chimeric VLPs elicited a strong and balanced antibody response towards the two target epitopes tested, although slight reductions were observed in the levels of specific serum antibody titers induced by bivalent chimeric VLPs as compared with the corresponding monovalent constructs. These results suggest that RHDV VLPs could represent a promising platform for the development of efficient multivalent vaccines.
Pathogenic variants of the J-domain protein DNAJC12 cause parkinsonism, which is associated with a defective interaction of DNAJC12 with tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. In this work, we characterize the formation of the TH:DNAJC12 complex, showing that DNAJC12 binding stabilizes both TH and the variant TH-p.R202H, associated with TH deficiency. This binding delays their time-dependent aggregation in an Hsp70-independent manner, while preserving TH activity and feedback regulatory inhibition by dopamine. DNAJC12 alone barely activates Hsc70 but synergistically stimulates Hsc70 ATPase activity when complexed with TH. Cryo-electron microscopy supported by crosslinking-mass spectroscopy reveals two DNAJC12 monomers bound per TH tetramer, each embracing one of the two regulatory domain dimers, leaving the active sites available for substrate, cofactor and inhibitory dopamine interaction. Our results also reveal the key role of the C-terminal region of DNAJC12 in TH binding, explaining the pathogenic mechanism of the DNAJC12 disease variant p.W175Ter.
Mycoviruses frequently coexist within fungal hosts, yet high-resolution structural studies have traditionally relied on the purification of individual viral species, limiting the structural analysis of naturally occurring mixed infections. Here, we show that single-particle cryo-electron microscopy (cryo-EM) can simultaneously resolve multiple coexisting mycoviruses directly from naturally virus-infected fungal hosts. Using Saccharomyces cerevisiae strain TF229, which naturally harbours the closely related totiviruses Saccharomyces cerevisiae virus L-A (ScV-L-A) and L-BC (ScV-L-BC), we separated both viral populations in silico and reconstructed their capsids at near-atomic resolution under identical experimental conditions. Despite sharing only 10% sequence identity, their capsid proteins retain a highly conserved structural fold, whereas a ∼20° difference in asymmetric dimer orientation remodels capsid curvature and generates distinct virion architectures. Structural comparison further highlighted the C-terminal extension of ScV-L-BC, which mediates molecular swapping between neighbouring subunits and contributes to capsid stabilization. Symmetry relaxation revealed that, in both viruses, the encapsidated genome adopts a conserved spool-like organization, with ordered dsRNA filaments arranged into concentric layers. The outermost genome layer remains separated by ∼10–15 Å from the inner capsid surface, consistent with its predominantly electronegative character, while specific capsid–genome contacts are maintained mainly through the C-terminal regions of Gag. These findings reveal how conserved capsid folds can generate structurally distinct viral particles and establish mixed-sample cryo-EM as a scalable strategy for the high-resolution characterization of complex mycovirus communities. IMPORTANCE: Fungal viruses are widabstacttespread and frequently occur as mixed infections, yet most structural studies rely on the purification of individual viruses, limiting our understanding of their diversity. This study demonstrates that cryo-electron microscopy can resolve closely related mycoviruses directly from naturally mixed samples, enabling their structural characterization under identical conditions. Application of this strategy to ScV-L-A and ScV-L-BC reveals how conserved capsid protein architectures can generate distinct viral particles and uncovers principles governing dsRNA genome organization. This work establishes a strategy to connect the rapidly expanding discovery of fungal viruses with structural and functional understanding.